Dr. Lovly is a physician-scientist with a special interest in thoracic malignancies. Her clinical practice focuses primarily on the care of patients with lung cancer. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.
She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O’Hare Chief Fellow. She started on faculty at Vanderbilt in the Department of Medicine, Division of Hematology-Oncology in July 2012.
She is the author of several peer-reviewed scientific manuscripts, and she is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). She is also deputy editor for the website My Cancer Genome, a Vanderbilt-initiated, freely available website that aims to provide healthcare practitioners, patients, and advocates with up-to-date information regarding genetically informed cancer medicine.
2017 LCFA/IASLC Lori Monroe Scholarship for Translational Lung Cancer Research
Dr. Lovly was chosen for the Class of 2017 of the Lung Cancer Foundation of America/International Association for the Study of Lung Cancer Lori Monroe Scholarships in Translational Lung Cancer Research. Her LCFA-funded research involves small cell lung cancer.